Product image of Mounjaro Kiwipen 5mg (Tirzepatide) 5MG/2.4ml Others supplied by GNH India

Mounjaro Kiwipen 5mg

Active Ingredient:
Tirzepatide
Form:
Others
Brand:
MOUNJARO
Origin:
Germany

Mounjaro Kiwipen 5mg (Tirzepatide Others) 5MG/2.4ml

Tirzepatide, the active ingredient in Mounjaro Kwikpen 5mg, is a dual GIP and GLP-1 receptor agonist presented as a 5mg/2.4ml injectable solution for subcutaneous use. It is indicated for the treatment of type 2 diabetes mellitus and weight management in adults. GNH India supplies Mounjaro Kwikpen 5mg as a licensed, GDP-compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Mounjaro Kwikpen 5mg is designed to help manage blood glucose levels and support weight reduction in individuals with type 2 diabetes or obesity-related conditions. The KwikPen delivery system ensures accurate and convenient dosing.

Strength

5MG/2.4ml

Pack Size

4s

Storage

2-8°

Manufacturer / TM Owner

Eli Lilly and Company Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

Mounjaro Kwikpen 5mg acts on the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, which are involved in glucose metabolism and appetite regulation.

  • Type 2 Diabetes Mellitus: Helps lower blood glucose levels in adults with type 2 diabetes.
  • Weight Management: Assists in weight reduction and management in adults with obesity (BMI ≥ 30 kg/m²) or overweight (BMI ≥ 27 kg/m²) with weight-related health issues.

How It Works

  • Tirzepatide activates both GIP and GLP-1 receptors, which enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite. This dual action helps regulate blood glucose levels and promote weight loss.

Side Effects

Mounjaro Kwikpen 5mg may cause various side effects, ranging from common to serious.

Common Side Effects

  • Nausea: Feeling sick to the stomach.
  • Diarrhea: Loose or watery stools.
  • Decreased Appetite: Reduced hunger or desire to eat.
  • Vomiting: Forceful expulsion of stomach contents.
  • Constipation: Difficulty passing stools.
  • Injection Site Reactions: Redness, swelling, or pain at the injection site.

Serious or Rare Side Effects

  • Pancreatitis: Inflammation of the pancreas, which can cause severe abdominal pain.
  • Hypoglycemia: Low blood sugar levels, which can lead to dizziness, sweating, and confusion.
  • Kidney Problems: Changes in kidney function, which may require monitoring.
  • Allergic Reactions: Severe allergic reactions, including rash, itching, and difficulty breathing.

Precautions & Warnings

Mounjaro Kwikpen 5mg should be used with caution and under medical supervision.

  • Consult a Healthcare Professional: Always use as directed by your doctor.
  • Monitor Blood Sugar: Regularly check blood glucose levels, especially when starting treatment.
  • Inform About Medical History: Tell your doctor about any history of pancreatitis, kidney problems, or allergic reactions.
  • Avoid During Pregnancy: Use during pregnancy should be discussed with a healthcare provider.
  • Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Mounjaro Kwikpen 5mg may interact with other medications, which can affect its efficacy or increase the risk of side effects.

Major Interactions (Avoid)

  • Insulin: Concurrent use may increase the risk of hypoglycemia.
  • Sulfonylureas: May enhance the blood sugar-lowering effects, leading to hypoglycemia.

Moderate Interactions (Monitor Closely)

  • Oral Medications: May affect the absorption of oral medications due to slowed gastric emptying.
  • Diuretics: May affect blood pressure and electrolyte balance.
  • Antihypertensives: May require dose adjustment due to changes in blood pressure.

Frequently Asked Questions

Mounjaro Kwikpen 5mg is used to treat type 2 diabetes mellitus and support weight management in adults. It helps lower blood glucose levels and reduce body weight in individuals with obesity or overweight with related health issues.

Tirzepatide, the active ingredient in Mounjaro Kwikpen 5mg, activates both GIP and GLP-1 receptors. This dual action enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite, helping to regulate blood glucose levels and promote weight loss.

The usual starting dose of Mounjaro Kwikpen 5mg is 2.5 mg once weekly for four weeks, followed by an increase to 5 mg once weekly. The dose may be further increased in 2.5 mg steps up to a maximum of 15 mg once weekly, as directed by your healthcare provider.

The safety of Mounjaro Kwikpen 5mg during pregnancy has not been established. It is important to consult with your healthcare provider before using this medication if you are pregnant or planning to become pregnant.

To order Mounjaro Kwikpen 5mg from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets and will ask you to confirm your trade or institutional credentials. The team will then provide pricing, availability, shipping details, and the necessary import paperwork.

Mounjaro Kwikpen 5mg is a dual GIP and GLP-1 receptor agonist, which sets it apart from other diabetes medications that may only target one of these receptors. This dual action can provide more comprehensive glucose control and weight management benefits.

Mounjaro Kwikpen 5mg should be stored at 2-8°C, kept refrigerated, and protected from light. Do not freeze or shake the pen. After first use, it can be stored at room temperature below 30°C for up to 30 days.

Mounjaro Kwikpen 5mg is administered as a subcutaneous injection, typically in the abdomen, thigh, or upper arm. The injection should be given on the same day each week, and the injection site should be rotated to prevent skin irritation.

The most serious risks associated with Mounjaro Kwikpen 5mg include pancreatitis, hypoglycemia, and kidney problems. It is important to monitor for symptoms such as severe abdominal pain, dizziness, and changes in urine output and to seek medical attention if these occur.

Mounjaro Kwikpen 5mg should not be used by individuals with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or those with a severe allergic reaction to Tirzepatide or any of the excipients in the formulation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Tirzepatide

MOUNJARO 2.5mg

MOUNJARO 2.5mg

2.5mgx0.5ml PFS
MOUNJARO 5mg

MOUNJARO 5mg

5mgx0.5ml PFS
MOUNJARO 7.5mg

MOUNJARO 7.5mg

7.5mgx0.5 ml PFS
MOUNJARO 10 mg

MOUNJARO 10 mg

10 mgx0.5 ml PFS

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT